CHASE VESSEL OCCLUDER— 510(k) K964390

Name: FDA 510(k) clearance K964390
Creator: U.S. Food and Drug Administration
Published: 1997-01-31

Substantially Equivalent

Chase Medical, Inc.

FDA 510(k) clearance K964390 for CHASE VESSEL OCCLUDER, Substantially Equivalent on 1997-01-31. Applicant: Chase Medical, Inc.. Device class: 2.

Clearance details

Applicant: Chase Medical, Inc.
Product code: Code MJN
Device class: Class 2
Regulation: 21 CFR 870.4450
Advisory panel: Cardiovascular
Date received: 1996-11-04
Decision date: 1997-01-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Richardson, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MJN

view all

K243795 — pREBOA-PRO Catheter2025-09-05
K251358 — Bridge Plus Occlusion Balloon (590-002)2025-06-24
K221294 — preCARDIA Occlusion System2023-06-30
K214060 — LANDMARK REBOA Catheter2022-09-19
K211610 — Fogarty Occlusion Catheter2022-02-14

More clearances from Chase Medical, Inc.

view all

K032531 — CHASE CARDIAC ANALYSIS SYSTEM2004-02-02
K022093 — CHASE CARDIOVASCULAR PATCH KIT2002-09-20
K021129 — CHARE CARIOVASCULAR PATCH2002-06-03
K020233 — CHASE CARDIOVASCULAR PATCH KIT2002-03-14
K020132 — CHASE CARDIOVASCULAR PATCH KIT2002-02-26

Adverse events under product code MJN

product code MJN

Death: 31
Injury: 240
Malfunction: 827
Total: 1,098

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.